AstraZeneca shares rise as UK coronavirus vaccine trial resumes
Shares of AstraZeneca AZN.L rose 1% to 8,516 pence on Monday after the British drugmaker received the go-ahead from safety watchdogs over the weekend to resume clinical trials for its COVID-19 vaccine candidate in the United Kingdom.
The…
Read More...
Read More...